Researchers Submit Patent Application, "Identifying Patient Populations Vulnerable To Viral Infection And Methods Of Inducing Heterologous Immunity In Same", for Approval (USPTO 20240181043).

A patent application has been submitted by researchers from nference Inc. for a method of identifying patient populations vulnerable to viral infection and inducing heterologous immunity. The method involves analyzing patient-specific data to assess the cross-protective effects of existing vaccines against SARS-COV-2 infection. By determining demographic covariates and propensity scores, the researchers aim to reduce the risk of acquiring or fully presenting a disease case by SARS-COV-2 infection. The method also involves administering vaccines that have not been given to the subject within the past year. Ongoing clinical trials are investigating the potential protective effects of existing vaccines against COVID-19 infection. [Extracted from the article]